1. MicroRNA‐26a inhibits proliferation and tumorigenesis via targeting CKS2 in laryngeal squamous cell carcinoma
   Zhiyan Wu et al, 2018, Clinical and Experimental Pharmacology and Physiology CrossRef
2. Integrated Bioinformatics Investigation of Novel Biomarkers of Uterine Leiomyosarcoma Diagnosis and Outcome
   Aleksandar Rakic et al, 2023, Journal of Personalized Medicine CrossRef
3. Depletion of Cks1 and Cks2 expression compromises cell proliferation and enhance chemotherapy-induced apoptosis in HepG2 cells
   LINGQING LIN et al, 2016, Oncology Reports CrossRef
4. High-expressed CKS2 is associated with hepatocellular carcinoma cell proliferation through down-regulating PTEN
   Xiaonan Ji et al, 2018, Pathology - Research and Practice CrossRef
5. Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma
   Chaohua Mo et al, 2022, BMC Medical Genomics CrossRef
6. CKS2 in human cancers: Clinical roles and current perspectives (Review)
   HANYU YOU et al, 2015, Molecular and Clinical Oncology CrossRef
7. Identification of core genes associated with prostate cancer progression and outcome via bioinformatics analysis in multiple databases
   Yutao Wang et al, 2020, PeerJ CrossRef
8. Expression of CKS2 in Hepatocellular Carcinoma: Correlation with Survival Outcomes and Immune Microenvironment
   Renhou Zhi et al, 2023, Journal of Hepatocellular Carcinoma CrossRef